Clinical trial
Phase II Study of ASP3550 - A Maintenance-dose Finding Study in Patients With Prostate Cancer
NCT00568516 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II Study of ASP3550 - A Maintenance-dose Finding Study in Patients With Prostate Cancer
- Lead sponsor
- Astellas Pharma Inc
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 31, 2007
- Completion date
- October 31, 2009
- Enrollment
- 273 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.